← The Wire
PHVSNasdaq
Pharvaris N.V.
Pharmaceutical Preparations · P7 · CIK 1830487
Pharvaris N.V. develops and commercializes therapies for hereditary angioedema
$2.15B
Market cap
$34.71
Last close
+2.1%
1D
+5.2%
5D
725K
Volume
Price · last 39 sessions+15.6%
May 4L $28.81 · H $34.71Jun 29
91
Total filings
Jun 26, 2026
Last filing
12/31
Fiscal year end
6-K6-KJun 26, 20266-K6-KJun 11, 20266-K6-KMay 12, 20266-K6-KMay 11, 2026424B5424B5May 8, 202620-F20-FApr 2, 20266-K6-KApr 2, 20266-K6-KJan 12, 20266-K6-KDec 3, 20256-K6-KNov 12, 20256-K6-KSep 8, 20256-K6-KAug 12, 20256-K6-KJul 24, 2025424B5424B5Jul 24, 2025424B5424B5Jul 22, 20256-K6-KJul 10, 20256-K6-KJun 27, 20256-K6-KJun 10, 20256-K6-KMay 13, 20256-K6-KApr 7, 202520-F20-FApr 7, 20256-K6-KJan 13, 20256-K6-KNov 13, 20246-K6-KSep 25, 20246-K6-KSep 23, 20246-K6-KSep 5, 20246-K6-KAug 14, 20246-K6-KJun 28, 20246-K6-KJun 11, 20246-K6-KJun 4, 20246-K6-KMay 8, 202420-F20-FApr 10, 20246-K6-KApr 10, 20246-K6-KMar 6, 20246-K6-KFeb 16, 20246-K6-KFeb 7, 20246-K6-KJan 22, 20246-K6-KJan 8, 20246-K6-KDec 8, 2023424B5424B5Dec 7, 20236-K6-KDec 6, 2023SC 13GSC 13GNov 30, 20236-K6-KNov 2, 2023424B5424B5Aug 24, 20236-K6-KAug 7, 20236-K6-KJul 3, 20236-K6-KJun 27, 20236-K6-KJun 26, 20236-K6-KJun 23, 20236-K6-KJun 20, 20236-K6-KJun 1, 20236-K6-KMay 8, 20236-K6-KApr 5, 202320-F20-FApr 5, 20236-K6-KMar 10, 20236-K6-KMar 8, 20236-K6-KFeb 14, 20236-K6-KJan 9, 20236-K6-KDec 8, 20226-K6-KDec 8, 20226-K6-KNov 1, 20226-K6-KSep 12, 20226-K6-K - PRESS RELEASE 22.08.2022Aug 22, 20226-K6-KJul 13, 20226-K6-KJun 29, 20226-K6-K- AGMJun 14, 20226-K6-K - PRESS RELEASE CLOMay 11, 20226-K6-KMay 11, 20226-K6-K - FY 2021 PRESS RELEASEMar 29, 202220-F20-FMar 29, 2022424B5424B5Mar 15, 2022SC 13GSC 13GFeb 9, 2022SC 13GSC 13GFeb 3, 20226-K6-KJan 10, 20226-K6-KDec 22, 20216-K6-KDec 7, 20216-KQ3 6-KNov 10, 20216-K6-K Q2 2021Jul 30, 20216-K6-K-2021-07-01Jul 1, 20216-K6-KJun 29, 2021
Similar companies
Comparable business profile · signals at a glance